the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:
.previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.
.
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.
.